Differential Distribution and Functional Quality of CMV-Specific T Cell Effector Memory in High-Risk Lung Transplant Recipients

被引：0
|
作者：
Akulian, J. A. [1 ]
Pipeling, M. R. [2 ]
John, E. R. [1 ]
McDyer, J. F. [2 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Univ Pittsburgh, Sch Med, PACCM, Pittsburgh, PA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2012年 / 31卷 / 04期
关键词：
D O I：
10.1016/j.healun.2012.01.411
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
401
引用
收藏
页码：S142 / S143
页数：2
相关论文
共 50 条
  • [41] Ganciclovir prophylaxis in CMV high-risk renal transplant recipients.
    Kletzmayr, J
    Safar, T
    Kovarik, J
    Klauser, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3210 - A3210
  • [42] Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV-specific T cells
    McGuire, Helen M.
    Rizzetto, Simone
    Withers, Barbara P.
    Clancy, Leighton E.
    Avdic, Selmir
    Stern, Lauren
    Patrick, Ellis
    Fazekas de St Groth, Barbara
    Slobedman, Barry
    Gottlieb, David J.
    Luciani, Fabio
    Blyth, Emily
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (07)
  • [43] Quantiferon-CMV Test, CMV-Specific ELISPOT and CMV-Dextramer Assays in Assessing the Risk of CMV Infection in Seropositive Kidney Transplant Recipients
    Lee, H.
    Park, K.
    Ryu, J.
    Yu, J.
    Chung, B.
    Yang, C.
    Oh, E. -J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 691 - 691
  • [44] CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study
    Sund, Fredrik
    Lidehall, Anna-Karin
    Claesson, Kerstin
    Foss, Aksel
    Totterman, Thomas H.
    Korsgren, Olle
    Eriksson, Britt-Marie
    CLINICAL TRANSPLANTATION, 2010, 24 (03) : 401 - 409
  • [45] A CMV-Specific T-Cell Assay Can Predict Future Recurrence of CMV in Liver Transplant Patients
    Sood, S.
    Haifer, C.
    Yu, J.
    Pavlovic, J.
    Gow, P.
    Jones, R.
    Visvanathan, K.
    Angus, P.
    Testro, A.
    TRANSPLANTATION, 2014, 98 : 179 - 179
  • [46] A CMV-Specific T-Cell Assay Can Predict Future Recurrence of CMV in Liver Transplant Patients
    Sood, S.
    Haifer, C.
    Yu, J.
    Pavlovic, J.
    Gow, P.
    Jones, R.
    Visvanathan, K.
    Angus, P.
    Testro, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 179 - 179
  • [47] Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation
    G Avetisyan
    K Larsson
    J Aschan
    C Nilsson
    M Hassan
    P Ljungman
    Bone Marrow Transplantation, 2006, 38 : 687 - 692
  • [48] Adoptive Immunotherapy With CMV-specific Cytotoxic T Lymphocytes for Stem Cell Transplant Patients With Refractory CMV Infections
    Bao, Lei
    Cowan, Morton J.
    Dunham, Kimberly
    Horn, Biljana
    McGuirk, Joseph
    Gilman, Andrew
    Lucas, Kenneth G.
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (03) : 293 - 298
  • [49] Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation
    Avetisyan, G.
    Larsson, K.
    Aschan, J.
    Nilsson, C.
    Hassan, M.
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2006, 38 (10) : 687 - 692
  • [50] The Ability of CMV-Specific Elispot Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients
    Ariza-Heredia, Ella J.
    Shah, Dimpy P.
    El Chaer, Firas
    El Haddad, Lynn
    El-Haddad, Danielle
    Prayag, Amrita
    Nesher, Lior
    Rezvani, Katy
    Shpall, Elizabeth J.
    Chemaly, Roy F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S175 - S175
12345